Kornek, M; Lynch, MC; Exley, MA et al.
Cell Microparticles: A Novel Marker of Hepatic Inflammation and Progression in Patients With HCV or NASHGASTROENTEROLOGY. Bd. 140. H. 5. 2011 S. S978-S978
Bier, C; Knauer, SK; Klapthor, A et al.
Cell-based Analysis of Structure-Function Activity of Threonine Aspartase 1JOURNAL OF BIOLOGICAL CHEMISTRY. Bd. 286. H. 4. 2011 S. 3007-3017
Staib, F; Weinmann, A; Krupp, M et al.
CELLMINER HCC: A MICROARRAY BASED EXPRESSION DATABASE FOR HEPATOCELLULAR CARCINOMA CELL LINESJOURNAL OF HEPATOLOGY. Bd. 54. 2011 S. S104-S104
Kruger, T; Weigang, E; Hoffmann, I et al.
Cerebral Protection During Surgery for Acute Aortic Dissection Type A Results of the German Registry for Acute Aortic Dissection Type A (GERAADA)CIRCULATION. Bd. 124. H. 4. 2011 S. 434-443
Moehler, M; Mueller, A; Trarbach, T et al.
Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II studyANNALS OF ONCOLOGY. Bd. 22. H. 6. 2011 S. 1358-1366
Wehrbein, H; Wriedt, S; Jung, BA
Change and innovation in orthodonticsBUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ. Bd. 54. H. 9. 2011 S. 1110-1115
Muxel, S; Radmacher, MC; Schafer, S et al.
Changes in endothelial function in healthy volunteers during soccer World Cup 2010 gamesINTERNATIONAL JOURNAL OF CARDIOLOGY. Bd. 152. H. 3. 2011 S. 395-396
Moroz, V; Machin, D; Faldum, A et al.
Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: A report from the International Neuroblastoma Risk Group ProjectEUROPEAN JOURNAL OF CANCER. Bd. 47. H. 4. 2011 S. 561-571
Hansmann, T; Heinzmann, J; Wrenzycki, C et al.
Characterization of Differentially Methylated Regions in 3 Bovine Imprinted Genes: A Model for Studying Human Germ-Cell and Embryo DevelopmentCYTOGENETIC AND GENOME RESEARCH. Bd. 132. H. 4. 2011 S. 239-247
Kukolj, G; Legace, L; Cartier, M et al.
CHARACTERIZATION OF HCV NS3 VARIANTS THAT EMERGED DURING VIROLOGIC BREAKTHROUGH AND RELAPSE FROM BI201335 PHASE 2 SILEN-C1 STUDYHEPATOLOGY. Bd. 54. 2011 S. 991A-991A